Bacterial signals may be harbinger for leukemia: study

          Source: Xinhua| 2018-05-17 03:06:14|Editor: Chengcheng
          Video PlayerClose

          WASHINGTON, May 16 (Xinhua) -- Researchers from the University of Chicago Medicine showed that bacterial signals might be a precursor condition to leukemia, which can be detected 10 to 15 years before the cancer develops.

          A new study published on Wednesday in the journal Nature revealed that the bacterial infection was induced in this case by the disrupted intestinal barrier and went usually without pathogens.

          According to the researchers, over 15 percent of people over the age of 60 develop TET2 mutations in hematopoietic stem cells that give rise to other blood cells, and those mutations give the hematopoietic stem cells a competitive advantage over others, so they begin to proliferate and make up a greater percentage of cells that become white blood cells.

          This is a condition known as clonal hematopoiesis of indeterminate potential, or CHIP, which can lead to a precursor condition to leukemia called pre-leukemic myeloproliferation.

          The new study, working on mice, has shown that progression from CHIP to pre-leukemic myeloproliferation is dependent on bacterial signals from bacteria normally present in the gut that spread to peripheral organs.

          The study demonstrated that loss of TET2 expression (in case of TET2 mutation) leads to defects in the intestinal barrier, allowing bacteria living in the gut, otherwise not pathogenic, to spread into the blood and peripheral organs.

          The spread of bacteria leads to the release of inflammatory molecules in the blood, which in turn promote the proliferation of hematopoietic stem cells that lack TET2 expression. This sets the stage for pre-leukemic myeloproliferation.

          "Years before a patient develops cancer, there are changes happening in the background. They still appear healthy until they reach a tipping point," said Bana Jabri, professor and vice chair for research in the Department of Medicine at University of Chicago and the senior author of the study.

          Genetic screening can detect TET2 mutations and early signs of changes in hematopoietic stem cells 10 to 15 years before cancer develops.

          This means that treatments to block the bacterial signals could reverse pre-leukemic myeloproliferation and limit the risk for developing cancer.

          TOP STORIES
          EDITOR’S CHOICE
          MOST VIEWED
          EXPLORE XINHUANET
          010020070750000000000000011100001371844521
          无码人妻一区二区三区四区av_亚洲精品911在线永久观看_精品一区二区国产在线观看_日韩不卡一区二区视频在线

                  亚洲人成色7777在线观看不卡 | 最新在线精品国自产拍视频 | 亚洲AV乱码二区三区涩涩屋 | 日本中文字幕一区在线 | 永久免费A在线观看全网站 亚洲日韩AV在线不卡 | 亚洲日韩最新一区二区三区 |